المؤلفون: Disel, Umut, Madison, Russell, Abhishek, Kumar, Chung, Jon H, Trabucco, Sally E, Matos, Asli O, Frampton, Garrett M, Albacker, Lee A, Reddy, Venkataprasanth, Karadurmus, Nuri, Benson, Adam, Webster, Jennifer, Paydas, Semra, Cabanillas, Ruben, Nangia, Chaitali, Ozturk, MA, Millis, Sherri Z, Pal, Sumanta K, Wilky, Breelyn, Sokol, Ethan S, Gay, Laurie M, Soman, Salil, Ganesan, Shridar, Janeway, Katherine, Stephens, Phil J, Zhu, Viola W, Ou, Sai‐Hong Ignatius, Lovly, Christine M, Gounder, Mrinal, Schrock, Alexa B, Ross, Jeffrey S, Miller, Vincent A, Klempner, Samuel J, Ali, Siraj M

المصدر: The Oncologist. 25(1)

مصطلحات موضوعية: Cancer, Rare Diseases, Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Gene Amplification, Humans, Middle Aged, Neoplasms, Receptor Protein-Tyrosine Kinases, Receptor, Platelet-Derived Growth Factor alpha, Vascular Endothelial Growth Factor Receptor-2, Young Adult, amplification, tyrosine kinase inhibitor, KIT, PDGFRA, genomic profiling, sarcoma, Oncology and Carcinogenesis, Oncology & Carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/90q0q2frTest

المؤلفون: Bahceci, Aykut, Ak, Naziye, Ferhatoglu, Ferhat, Saip, Pinar Mualla, Seydaoglu, Gulsah, Paydas, Semra, Bilici, Mehmet

مصطلحات موضوعية: T-DM1, Metastatic breast cancer, efficacy, toxicity, real-world experience, Survival, Receptor

العلاقة: Cancer Investigation; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/11454/77154Test; https://doi.org/10.1080/07357907.2021.1933011Test; Paydas, Semra/0000-0003-4642-3693; Ferhatoglu, Ferhat/0000-0002-7651-6789; Şahin, Ahmet Bilgehan/0000-0002-7846-0870; beypınar, İsmail/0000-0002-0853-4096; Simsek, Melih/0000-0003-0633-8558; Bulut, Gülcan/0000-0001-7382-0972; Karaçin, Cengiz/0000-0002-7310-9328; 39; 6-7; 473; 481

الإتاحة: https://doi.org/10.1080/07357907.2021.1933011Test
https://hdl.handle.net/11454/77154Test

المؤلفون: KÖSTEK, OSMAN, YUMUK, PERRAN FULDEN

المساهمون: Bahceci, Aykut, Paydas, Semra, Ak, Naziye, Ferhatoglu, Ferhat, Saip, Pinar Mualla, Seydaoglu, Gulsah, Bilici, Mehmet, Simsek, Melih, Tekin, Salim Basol, Calikusu, Zuleyha, Yavuz, Sinan, Sahin, Ahmet Bilgehan, Cubukcu, Erdem, Evrensel, Turkkan, Degirmencioglu, Serkan, Demiray, Atike Gokcen, Yumuk, Perran Fulden, Alan, Ozkan, Cikman, Duygu Ilke, Demirelli, Fuat Hulusi, Kostek, Osman, Gokyer, Ali, Dogan, Mutlu, Bal, Oznur, Cakar, Burcu, Gokmen, Erhan, Yamac, Deniz, Korkmaz, Taner, Aliyev, Altay, Keskin, Ozge, Urvay, Semiha, Buyuksimsek, Mahmut, Karadeniz, Cemile, Yildiz, Birol, Cinkir, Havva Yesil, Demir, Hacer, Beypinar, Ismail, Karacin, Cengiz, Eser, Kadir, Baykara, Meltem, Kilickap, Saadettin, Okutur, Kerem, Bulut, Gulcan, Alkan, Ali, Arpaci, Erkan, Pilanci, Kezban Nur, Demir, Atakan, Isik, Deniz, Yildirim, Nilgun

مصطلحات موضوعية: Metastatic breast cancer, T-DM1, efficacy, toxicity, real-world experience, SURVIVAL, RECEPTOR

العلاقة: CANCER INVESTIGATION; https://hdl.handle.net/11424/237317Test; WOS:000658617100001

الإتاحة: https://doi.org/10.1080/07357907.2021.1933011Test
https://hdl.handle.net/11424/237317Test

المساهمون: Icli, Fikri, Altundag, Kadri, Akbulut, Hakan, Paydas, Semra, Basaran, Gul, Saip, Pinar, Dogu, Gamze G., Erlap, Yesim, Uslu, Ruchan, Sevinc, Alper, Onur, Handan, Mandel, Nil M., Sezgin, Canfeza, Altinbas, Mustafa, Guler, Nilufer, Isikdogan, Abdurrahman, Gokmen, Erhan, Uygun, Kazim, Ustuner, Zeki, Yaren, Arzu, Demirkan, Binnaz, Coskun, Ugur, Ata, Alper, Ozkan, Metin, Arican, Ali

مصطلحات موضوعية: Adjuvant treatment, Nine weeks trastuzumab, Cardiotoxicity, Early breast cancer, CHEMOTHERAPY, XENOGRAFTS, ANTIBODY, RECEPTOR, THERAPY

العلاقة: BREAST CANCER; https://hdl.handle.net/11424/233606Test; WOS:000363722200006

الإتاحة: https://doi.org/10.1007/s12282-013-0506-yTest
https://hdl.handle.net/11424/233606Test